Abstract
It is known that the prognosis of breast cancer is related to the stage of the disease when treated, implying that earlier diagnosis means a better prognosis. It is also known that mammography has the potential to detect breast cancer in a non-palpable and sometimes even non-invasive stage. This is the basis for mammographic screening programs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shapiro S, Venet W, Strax P, Venet L (1988) Current results of the breast cancer screening randomized trial: The Health Insurance Plan (HIP) of Greater New York Study. In: NE Day, AB Miller (eds.), Screening for breast cancer, Huber, Toronto, pp 3–15.
Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F et al (1988) Mammographic screening and mortality from breast cancer: the Malmö Mammographic Screening Trial. BMJ 297, pp 943–948.
Tabár L, Fagerberg G, Duffy SW, Day NE (1989) The Swedish two-country trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 43, pp 107–114.
Tabár L, Fagerberg CJG, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G et al (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1, pp 829–832.
Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, Hepburn W, Huggins A, Kirkpatrick AE, Lamb J et al (1990) Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 335, pp 241–246.
Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 147, pp 1459–1476.
Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study:2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 147, pp 1477–1488.
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A (1991) Randomized study of mammography screening — preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18, pp 49–56.
Bjurstam N, Björneid L, Duffy SW, Smith TC, Cahlin E, Erikson O et al (1997) The Gothenburg Breast Cancer Screening Trial: Preliminary results on breast cancer mortility for women aged 39–49. J Natl Cancer Inst Monogr 22, pp 53–55.
Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L, Larsson LG (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341, pp 973–978.
Palli D, Rosselli del Turco M, Buiatti E et al (1986) A case control study of the efficacy of a nonrandomised breast cancer screening program in Florence (Italy). Int J cancer 38, pp 501–504.
Collette HJA, Day NE, Rombach JJ, de Waard F (1984) Evaluation of screening for breast cancer in an non-randomized study (the DOM project) by means of a case-control study. Lancet 1, pp 1224–1226.
Verbeek ALM, Hendricks JHCL, Holland R, Mravunac M, Strumans F, Day NE (1984) Reduction in breast cancer mortality through mass screening with modern mammography. (First results of the Nijmegen Project 1975–1981). Lancet 1, pp 1222–1224.
Larsson L-G, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, Nyström L (1997) Updated overview of the Swedish randomized trials on breast cancer screening with mammography: Age group 40–49 at randomization. J Natl Cancer Inst Monogr 22, pp 57–61.
Andersson I, Janzon L (1997) Reduced breast cancer mortality in women under age 50: Updated results from the Malmö mammograhic screening program. J Natl Cancer Inst Monogr 22, pp 63–67.
Bjurstam N, Björneid L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafström L-O, Lingaas H, Mattsson J, Persson S, Rudenstam C-M, Säve-Söderbergh J (1997) The Gothenburg Breast Screening Trial. First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 80, pp 2091–2099
Miller AB, To T, Baines CJ, Wall C (1997) The Canadian National Breast Screening Study: Update on breast cancer mortality. J Natl Cancer Inst Monogr 22, pp 37–41.
Nyström L, Larsson LG, Wall S, Rutqvist LE, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L (1996) An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts. J Med Screen 3, pp 85–87.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Andersson, I. (1998). Breast Cancer Screening Results. In: Karssemeijer, N., Thijssen, M., Hendriks, J., van Erning, L. (eds) Digital Mammography. Computational Imaging and Vision, vol 13. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5318-8_71
Download citation
DOI: https://doi.org/10.1007/978-94-011-5318-8_71
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6234-3
Online ISBN: 978-94-011-5318-8
eBook Packages: Springer Book Archive